Market Cap 4.21M
Revenue (ttm) 0.00
Net Income (ttm) -7.32M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.04
Volume 14,600
Avg Vol 165,280
Day's Range N/A - N/A
Shares Out 620,000.00
Stochastic %K 29%
Beta 0.91
Analysts Sell
Price Target $18.00

Company Profile

Biodexa Pharmaceuticals Plc, a clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of familial adenomatous polyposis, non-muscle invasive bladder cancer, and Type 1 diabetes and rare/orphan cancers of the brain. Its lead product candidate Tolimidone, a selective activator of the lyn kinase enzyme, currently under Phase II studies for the treatment of Type 1 diabetes. The company is also developing MTX110, which is currently in Phase I studies...

Industry: Biotechnology
Sector: Healthcare
Phone: 44 29 2048 0180
Address:
1 Caspian Point, Caspian Way, Cardiff, United Kingdom
invinc1ble
invinc1ble Oct. 25 at 3:20 PM
$BDRX can do 100% overnight
0 · Reply
prakritim
prakritim Oct. 22 at 4:10 AM
$BDRX $PSTV long intact IS the trap of mo
0 · Reply
Tommyj1014
Tommyj1014 Oct. 21 at 2:33 PM
$BDRX ST your numbers are wrong.
0 · Reply
Vulnerable
Vulnerable Oct. 19 at 12:40 AM
$BDRX $PSTV This is an example of "long intact" BDRX, formerly MTP before the ticker change, was $712,000 value on 4/20/21. When Mo says long intact, he means okay to buy short because he's shorting it to oblivion.
0 · Reply
Tommyj1014
Tommyj1014 Oct. 17 at 7:29 PM
$BDRX Still waiting for a decent pop
0 · Reply
KingsOnly
KingsOnly Oct. 16 at 7:14 PM
$BDRX decent news last month
0 · Reply
ForeverBulls
ForeverBulls Oct. 15 at 6:34 PM
$BDRX swinging it
0 · Reply
Love_To_Learn
Love_To_Learn Oct. 15 at 10:58 AM
$BDRX CODING U IN PARTS N PIECES USING TBH 1.44* NOW MY BEUD
0 · Reply
outrich
outrich Oct. 15 at 8:13 AM
0 · Reply
AstroSwings
AstroSwings Oct. 14 at 7:57 PM
$BDRX should run soon
0 · Reply
Latest News on BDRX
Interim results for the six months ended June 30, 2025

Sep 12, 2025, 8:30 AM EDT - 6 weeks ago

Interim results for the six months ended June 30, 2025


ADR Ratio Change Effective

Jul 31, 2025, 9:30 AM EDT - 3 months ago

ADR Ratio Change Effective


ADR Ratio Change

Jul 15, 2025, 4:30 PM EDT - 3 months ago

ADR Ratio Change


Results of Annual General Meeting

Jun 27, 2025, 8:30 AM EDT - 4 months ago

Results of Annual General Meeting


Result of General Meeting

Jun 11, 2025, 4:30 PM EDT - 4 months ago

Result of General Meeting


Shareholder Update

May 30, 2025, 8:30 AM EDT - 5 months ago

Shareholder Update


Notice of General Meeting

Apr 17, 2025, 8:30 AM EDT - 6 months ago

Notice of General Meeting


Preliminary Results for the Year Ended 31 December 2024

Apr 11, 2025, 8:30 AM EDT - 7 months ago

Preliminary Results for the Year Ended 31 December 2024


Biodexa Announces Successful Appeal of Nasdaq Delisting

Oct 15, 2024, 4:15 PM EDT - 1 year ago

Biodexa Announces Successful Appeal of Nasdaq Delisting


invinc1ble
invinc1ble Oct. 25 at 3:20 PM
$BDRX can do 100% overnight
0 · Reply
prakritim
prakritim Oct. 22 at 4:10 AM
$BDRX $PSTV long intact IS the trap of mo
0 · Reply
Tommyj1014
Tommyj1014 Oct. 21 at 2:33 PM
$BDRX ST your numbers are wrong.
0 · Reply
Vulnerable
Vulnerable Oct. 19 at 12:40 AM
$BDRX $PSTV This is an example of "long intact" BDRX, formerly MTP before the ticker change, was $712,000 value on 4/20/21. When Mo says long intact, he means okay to buy short because he's shorting it to oblivion.
0 · Reply
Tommyj1014
Tommyj1014 Oct. 17 at 7:29 PM
$BDRX Still waiting for a decent pop
0 · Reply
KingsOnly
KingsOnly Oct. 16 at 7:14 PM
$BDRX decent news last month
0 · Reply
ForeverBulls
ForeverBulls Oct. 15 at 6:34 PM
$BDRX swinging it
0 · Reply
Love_To_Learn
Love_To_Learn Oct. 15 at 10:58 AM
$BDRX CODING U IN PARTS N PIECES USING TBH 1.44* NOW MY BEUD
0 · Reply
outrich
outrich Oct. 15 at 8:13 AM
0 · Reply
AstroSwings
AstroSwings Oct. 14 at 7:57 PM
$BDRX should run soon
0 · Reply
Metal_Health
Metal_Health Oct. 13 at 7:21 PM
$BDRX been accumulating back in the $7's and $8's offering will come after it blows up not before...classic tree shake. Originally alerted in $5's it hit $16.91 last week.
1 · Reply
MarketMasterMind
MarketMasterMind Oct. 13 at 4:54 PM
$CHNR | $CLIK | $BLBX | $BDRX Ⓜ️
0 · Reply
MarketMasterMind
MarketMasterMind Oct. 13 at 3:57 PM
Low-float & momentum shaping up — keep an eye on: $CHNR | $CLIK | $BLBX | $BDRX | $UPC Volume + catalysts could spark a run ⚡️ Trade Smart | Stay Hungry | Stay Humble Ⓜ️
0 · Reply
jadeite_haystack
jadeite_haystack Oct. 12 at 8:44 PM
$BDRX this thing is going to come down around $8.60 then be off to the races again. Target $22.+
0 · Reply
StockChiefs
StockChiefs Oct. 12 at 5:47 PM
MTEX has only 600k shares outstanding and started to make its move up Friday! Don't miss MTEX . I would rather buy before they run 200% up.. 💎 Spiked towards $15 recently . Looks like once people find MTEX we could see a squeeze up again! $BHAT $BDRX $QNRX $GCTK have low floats!
0 · Reply
Love_To_Learn
Love_To_Learn Oct. 10 at 9:48 PM
$BDRX WERE GONNA HAVE TO FIX FEW THINGS BEUD THESE CRYPTO PEOPLE GONNA LOOSE THEIR MINDS LOL
1 · Reply
Love_To_Learn
Love_To_Learn Oct. 10 at 9:43 PM
$BDRX LOOK WHAT U DID BEUD TO CRYPTO HAD TO TAME U BAXK TODAY U CAUSED A BIT OF CHAOS LOL GOOD GIRL
0 · Reply
mahmoud58
mahmoud58 Oct. 10 at 7:14 PM
$BDRX I asked chatgpt about a statement in their news dated on 6 October: Isn’t this statement an indication that they will likely present positive data? "The insights shared will be invaluable as we continue to advance our Phase 3 Serenta trial and work toward potentially providing the first approved therapy for FAP patients." Chatgpt answered : Yes ✅ — the statement strongly suggests that the company expects — or is preparing investors for — positive data. Here’s the reasoning in detail: 🔍 Linguistic and practical analysis of the statement Key phrases: “invaluable” → usually used when something is very useful or encouraging. “continue to advance” → implies the trial is progressing successfully, with no major setbacks. “potentially providing the first approved therapy” → conveys a sense of confidence in the drug’s path toward approval, not just early testing. In biotech communications , companies rarely use such optimistic language unless the early or interim results look promising.
0 · Reply
Love_To_Learn
Love_To_Learn Oct. 10 at 6:40 PM
$BDRX changed your afterhours
0 · Reply
DrCM
DrCM Oct. 10 at 5:54 PM
$BDRX I own 3,600 shares (about 0.6%) at an average price of $12. I'm never going to sell. Someone will want to buy, and if I don't, the stock will go up. Let's wait and see the Phase 3 clinical trial results.
0 · Reply
Metal_Health
Metal_Health Oct. 10 at 5:42 PM
$BDRX back in @ $8.60 this is when to buy, buy the red most will not. Thank you TGI Friday.
0 · Reply
moneytra1n
moneytra1n Oct. 10 at 5:42 PM
$SPY $NUWE $BDRX "Everythings fine". Good track record for that lie. Eerily similar lies over the years, no? Emotions and ego not in check. Trade smart people, avoid the lies or short them with both hands.
0 · Reply